FIELD: medicine, pharmacy. SUBSTANCE: solid nonporous microsphere has diameter 1-300 mcm and made of one or some pharmaceutically active substances at melting point above 60 C. Microsphere can contain additionally special additions as stabilizing or structurizing agents for an active component. Pharmaceutically active substance is taken from steroids, for example, progesterone, 17-β-estradiol or from analgetics, for example, naproxen, indomethacin. Method of microsphere producing involves the following stages: an active component is melted in inert atmosphere, melt is sprayed in freezing chamber at temperature from -15 to -50 C under pressure of inert atmosphere as mist consisting of the smallest drops. Drops were frozen and obtained microspheres were separated for fractions by size. Above 70% obtained microspheres have diameter 70-130% of required diameter value. Suspension designed for parenteral administration by injection has an effective amount of described microspheres distributed in pharmaceutically acceptable liquid vector. Liquid medium is an aqueous salt solutions, for example, physiological solution, or oils. An active component of microsphere is insoluble in indicated liquid medium. Suspension can be contraceptive formula or that for osteoporosis prophylaxis in women at menopause. EFFECT: improved method of producing and quality. 17 cl, 22 dwg
Title |
Year |
Author |
Number |
NON-POROUS MICROSPHERES ADAPTED FOR PARENTERAL ADMINISTRATION, METHOD FOR PREPARING SAME AND SUSPENSION BASED ON SAID MICROSPHERES |
1991 |
- Khuan Ankheles Uribe[Mx]
- Khose Garsa Flores[Mx]
|
RU2095055C1 |
MICROCRYSTALS, METHOD OF PREPARING MICROCRYSTALS, AND PHARMACEUTICAL COMPOSITION |
1991 |
|
RU2126013C1 |
MICROSPHERES HAVING NUCLEUS/COATING STRUCTURE |
2008 |
|
RU2485941C2 |
MACROMOLECULAR MICROSPHERE TECHNOLOGY |
2012 |
- Fang Fang
- Malakhov Majkl P.
|
RU2628807C2 |
PARENTERAL PHARMACEUTICAL FORMULATION IN SUSPENSION, HAVING SUSTAINED RELEASE, IN LOW AND ULTRALOW DOSAGE, IN HORMONAL THERAPY IN CLIMACTERIC SYNDROME |
2010 |
- Ankheles Uribe Khuan
- Savuar Vilbef Dzhon Klod
|
RU2582272C2 |
IMPLANT FOR SUBCUTANEOUS OR INTRACUTANEOUS INJECTION |
1998 |
- Azijus Zherom
- Fessi Atem
- Gushe Frank
- Laglenn Benedikt
- Lozh'E-Laglenn Ehlizabet
|
RU2214283C2 |
SUSTAINED RELEASE SYSTEMS AND LOW DOSES OF ANDROGENS, METHODS OF THEIR PREPARING AND METHOD OF TREATMENT USING THESE SYSTEMS |
1992 |
- Fernan Labri
- Marten Lepazh
|
RU2142276C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF MICROSPHERES FOR PREVENTION OF EXTREMITY AMPUTATION IN CASE OF DIABETES |
2007 |
- Saes Martines Vivian Marija
- Paes Mejreles Rolando
- Berlanga Akosta Khorkhe Amador
- Betankourt Rodriges Blas Jamir
- Ramon Ehrnandes Khose Ankhel
|
RU2426528C2 |
ARIPIPRAZOLE EXTENDED RELEASE MICROSPHERE AND A METHOD OF ITS PRODUCTION |
2018 |
- Chen, Bin
- Yin, Xia
- Wang, Yanqing
- Xu, Peng
- Yang, Yuda
- Chen, Miaoli
- Ye, Weilun
- Lv, Linyan
- Xu, Huijuan
- Lu, Wenqi
- Kong, Xiangsheng
- Jiang, Xiaoman
|
RU2800062C2 |
COMPOSITION IN THE FORM OF MICROSPHERES FOR PROLONGED AND CONTROLLED RELEASE OF PEPTIDE MEDICINAL SUBSTANCE |
1992 |
- Frederik Khajmgartner[Ch]
- P'Ero Orsolini[Ch]
|
RU2103994C1 |